Loading…
Alembic Pharmaceuticals (APLLTD)₹1,017+0.72%Pharmaceuticals
At the end of the Jun 2026 quarter, Alembic Pharmaceuticals' shareholders were: promoters 69.88%, FIIs 4.18%, DIIs 15.91%, public 10.03%. Promoter holding is up 0.13 percentage points from 69.75% a quarter earlier. FII holding is up 0.21 percentage points from 3.97% a year earlier. 0.00% of promoter shares were pledged. It had 86,823 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.62% | 69.62% | 69.62% | 69.62% | 69.62% | 69.62% | 69.68% | 69.69% | 69.75% | 69.75% | 69.75% | 69.88% |
| FIIs | 4.52% | 4.53% | 4.47% | 4.33% | 3.95% | 4.18% | 3.95% | 3.97% | 4.05% | 4.24% | 4.27% | 4.18% |
| DIIs | 14.20% | 14.49% | 15.37% | 15.45% | 16.03% | 16.03% | 16.41% | 16.44% | 16.28% | 16.15% | 16.15% | 15.91% |
| Public | 11.66% | 11.36% | 10.54% | 10.60% | 10.40% | 10.17% | 9.96% | 9.90% | 9.92% | 9.86% | 9.83% | 10.03% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 89,580 | 85,239 | 76,591 | 74,852 | 91,457 | 93,973 | 91,364 | 89,041 | 89,997 | 87,027 | 86,459 | 86,823 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Nirayu Private Limited | Promoter | 35.79% | +0.13 |
| Alembic Limited | Promoter | 28.58% | 0.00 |
| Life Insurance Corporation Of India | DII | 4.31% | 0.00 |
| Dsp Small Cap Fund | DII | 3.82% | New |
| Chirayu Ramanbhai Amin | Promoter | 2.14% | 0.00 |
| Kotak Small Cap Fund | DII | 1.73% | 0.00 |
| Malika Chirayu Amin | Promoter | 1.52% | 0.00 |
| Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund | DII | 1.39% | +0.26 |
| Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap Fund | DII | 1.14% | −0.66 |
| Pranav Chirayu Amin | Promoter | 0.51% | 0.00 |
| Shaunak Chirayu Amin | Promoter | 0.51% | 0.00 |
| Udit Chirayu Amin | Promoter | 0.51% | 0.00 |
| Chirayu Ramanbhai Amin HUF | Promoter | 0.11% | 0.00 |
| Gallup Trust (Pranav Chirayu Amin) | Promoter | 0.05% | 0.00 |
| Inaaya Shaunak Amin | Promoter | 0.04% | 0.00 |
| Naintara Shaunak Amin | Promoter | 0.04% | 0.00 |
| Barkha Pranav Amin | Promoter | 0.03% | 0.00 |
| Krupa Shaunak Amin | Promoter | 0.03% | 0.00 |
| Satori Trust (Chirayu Ramanbhai Amin) | Promoter | 0.03% | 0.00 |
| Ranvir Pranav Amin | Promoter | 0.02% | 0.00 |
| Samira Pranav Amin | Promoter | 0.02% | 0.00 |
| Dsp Midcap Fund | DII | Exited | — |
Promoters held 69.88% of Alembic Pharmaceuticals at the end of the Jun 2026 quarter, up 0.19 percentage points from 69.69% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 4.18% (down 0.09 percentage points from 4.27% a quarter earlier) and domestic institutions (DIIs) held 15.91% (down 0.24 percentage points from 16.15% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Alembic Pharmaceuticals had 86,823 shareholders at the end of the Jun 2026 quarter, against 89,041 a year earlier.
Life Insurance Corporation Of India (DII) held 4.31% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.